Internal Medicine, MedStar Georgetown Washington Hospital Center, Washington, DC, USA.
Internal Medicine, MedStar Georgetown Washington Hospital Center, Washington, DC, USA
BMJ Case Rep. 2020 Nov 30;13(11):e235859. doi: 10.1136/bcr-2020-235859.
A 57-year-old man with mild haemophilia B was admitted for coronary artery bypass graft surgery. His factor IX (FIX) activity was 15% on admission. Our goal was to maintain his FIX activity at 80%-100% for post-op days (PODs) 0-3, and at 60%-80% for PODs 4-14. Preoperatively, the patient was given recombinant FIX (rFIX) bolus using the formula:Dosage needed=%(desired FIX level-current level of FIX)×weight (kg)×1.3.This increased his activity to 100%. One IU of rFIX increased FIX activity by 0.8%; the half-life of rFIX is 18-24 hours. The rFIX infusion was started intraoperatively and continued after surgery to maintain target FIX activity. He was discharged on POD 9 on rFIX bolus dosing of 5000 IU every 12 hours for an additional 5 days. Using continuous factor infusion, we managed to decrease the amount rFIX used by >60% while maintaining steady state FIX activity level.
一位 57 岁轻度乙型血友病男性患者因冠状动脉旁路移植术入院。他入院时的因子 IX(FIX)活性为 15%。我们的目标是在术后第 0-3 天将他的 FIX 活性维持在 80%-100%,在术后第 4-14 天维持在 60%-80%。术前,根据公式给予患者重组 FIX(rFIX)推注:所需剂量=[(目标 FIX 水平-当前 FIX 水平)×体重(kg)×1.3]%。这将他的活性提高到了 100%。1IU 的 rFIX 可提高 FIX 活性 0.8%;rFIX 的半衰期为 18-24 小时。rFIX 输注在手术期间开始,并在手术后继续以维持目标 FIX 活性。他在术后第 9 天出院,rFIX 推注剂量为 5000IU,每 12 小时一次,持续 5 天。通过持续因子输注,我们成功地将 rFIX 的使用量减少了 60%以上,同时保持了稳定的 FIX 活性水平。